International Expansion of Indian Pharmaceutical Companies: Trends, Strategies, and Outlook
DOI:
https://doi.org/10.22270/ajprd.v13i6.1684Abstract
The Indian pharmaceutical industry has rapidly grown from being a domestic generics supplier to a global healthcare contributor. Today, Indian companies supply nearly 20% of the world’s generic medicines and around 60% of vaccines, positioning the sector as a global lifeline. This paper reviews the industry’s expansion strategies, export trends, and future opportunities while highlighting regulatory hurdles, raw material dependencies, and the industry’s future lies in biosimilars, specialty medicines, and innovation-led growth.
Downloads
References
Kumar, V., & Patel, M. Generic Drug Penetration in Africa. Journal of Pharmaceutical Policy and Practice, 2023; 16(1):1–12
Chaudhuri, S., & Banerjee, A. Export Dynamics in the Indian Pharmaceutical Sector. Journal of International Business Studies, 2022; 53(4):789–804
Joseph, R. K., Dhar, B., & Singh, A. A. (2019). FDI in R&D in India: An analysis of recent trends (ISID Working Paper No. 209). Institute for Studies in Industrial Development.
Patel, D., Singh, D. K., Patel, B., & Borkhataria, C. Impact and overview of track and trace system and serialization in pharmaceutical industry. Indian Journal of Pharmacy & Pharmacology, 2021; 8(1):47-51.
KPMG. (2023). Supply Chains Post-COVID-19: Asia-Pacific Pharmaceuticals Overview. KPMG Asia Pacific.
Padmanabhan, R. Unleashing biotech’s crouching tiger. Nature Biotechnology, 2019; 37(7):699-704.
Selvaraj, S., Farooqui, H. H., Mehta, A., et al. (2022) Journal of Pharmaceutical Policy and Practice, 15, Article 68.
Mettl. (2023). India’s Graduate Skill Index 2023. Mercer | Mettl.
Indian Brand Equity Foundation. (2025, April). Pharmaceutical Exports from India.
India Brand Equity Foundation. (2024). Pharmaceutical Exports from India. IBEF.
Mane P. Global Biologics Market 2022. Altus Market Research; 2022.
KPMG India. (2022, April). Impact of the Pharma Industry on the Indian Economy in the Post-COVID Era. KPMG.
India, Ministry of Chemicals & Fertilizers, Department of Pharmaceuticals. (2023). Boosting of Medical Devices Industry – Report 2023. Government of India
Chaudhuri, S. The Political Economy of Pharmaceutical Patent Protection. World Development, 2005; 33(2):239–253.
Lanjouw . J. O. The Introduction of Pharmaceutical Product Patents in India. Journal of International Economics, 1998; 45(1):97–123.
Berger, M. L., et al. Globalization of Pharmaceutical Markets. Health Affairs, 2004; 23(3):48–58
Gereffi, G. The Global Pharmaceutical Industry. Industry and Innovation, 2005; 12(2):153–176.
Kumar, S., et al. Generic Drug Competition in the US. Health Policy, 2011; 100(1):33–45.
Danzon, P. M., & Epstein, A. M. The Economics of Biosimilars. Health Affairs, 2008; 27(3):649–660.
Malpani, A., & Udupa, K. India’s Pharmaceutical R&D. Journal of Commercial Biotechnology, 2014; 20(1):12–20
Pisano, G. P. Science Business. Harvard Business Review, 2006; 84(10):114–125.
GaBI Journal. Biosimilars in Emerging Markets. Generics and Biosimilars Initiative Journal, 2020; 9(2):56–63.
Nature Biotechnology. Lipid Nanoparticles for RNA Delivery. 2019; 37(10):1109–1118.
IEEE Transactions on Biomedical Engineering. (2021). AI in Drug Discovery.2021; 68(5):1422–1430
Kumar, V., & Singh, P. Globalization of Indian Pharmaceuticals: Trends and Strategies. Journal of International Business Studies, 2023; 54(2):245-263.
Chaudhuri, S., & Banerjee, A. (2022). Export Dynamics in the Indian Pharmaceutical Sector. Journal of International Business Studies, 2022; 53(4):789–804
Gupta, R., et al. M&A Strategies in Emerging Market Pharma. Harvard Business Review (Asia Pacific), 2023; 12(1):45–60.
PwC India. Pharma 2025: The Next Wave of Growth. PwC Research Report, 2023; 45–67.
McKinsey & Company. Value Creation in Pharma M&A. McKinsey Quarterly, 2022; 4:89–102.
Nature Biotechnology. AI in Drug Discovery: Case Studies from India. 2024; 32(3):210–225
Shah, R., et al. Global Generic Drug Market Dynamics: India’s Role. Journal of Pharmaceutical Policy and Practice, 2023; 16(1): 45–62.
López, M., & García, P. Pharmaceutical Market Trends in Latin America. Health Policy and Planning, 2024; 39(3):211–228.
World Health Organization. Global HIV/AIDS Treatment Access Report. WHO Bulletin, 2023; 101(5):345–360.
Sharma, P., & Gupta, V. Sun Pharma-Ranbaxy integration: A turnaround framework. International Journal of Pharmaceutics, 2016; 510(1):212-225.
Pisano, G. P. Science Business. Harvard Business Review, 2006; 84(10), 114–125
Rao, K., et al. (2023). Supply chain resilience in pharma M&A: Lessons from the 2022 API crisis. Journal of Supply Chain Management, 59(2), 34-51.
Patel, R., et al. Regulatory arbitrage in generic drug markets: A case study of EU’s revised GMP norms. Nature Reviews Drug Discovery, 2021; 20(5):389-401.
Jumper, J., Evans, R., Pritzel, A., et al. Highly accurate protein structure prediction with AlphaFold. Nature, 2021; 596:583–589.
Rakholia, R., Suárez-Cetrulo, A. L., Singh, M., & Simón Carbajo, R. (2025). Integrating AI and IoT for Predictive Maintenance in Industry 4.0 Manufacturing Environments: A Practical Approach. Information, 16(9), Article 737.
Khangan, V. R., & Tiple, R. H. The Challenge of Counterfeit Medicine in Indian Market: A ComprehensiveReview. Indian Journal of Pharmacy Practice, 2025; 18(4):352-361
Khan, M. A. A., Farooqui, H., & Sharma, S. (2024). Promoting local production and active pharmaceutical ingredients in India. Therapeutic Innovation & Regulatory Science.
Dwivedi, R., Agarwal, V., & Choudhury, P. (2023). Learning for Indian medical device ecosystem. Indian Journal of Medical Devices & Diagnostics [or similar journal].
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Singh Deeksha, Jadhav Diksha
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
. 